Dr. Joseph J. Fins, Chief, Division of Medical Ethics, WDOM, has been appointed as President of the International Neuroethics Society (INS). Dr. Fins is serving a a two-year term during which time he will guide efforts to encourage and inspire research and dialogue on the responsible use of advances in brain science. Dr. Fins will chair a 15-member Board in his new role as the sixth president of the INS.
"It's a good time to be in neuroethics," said Dr. Fins. "It's never been more important, because neuroscience is on the march." In his welcome address at the INS Annual Meeting on November 5, 2021, Dr. Fins outlined several priorities for the INS: increase membership with targeted outreach to the neuropsychiatric and medical community, to help patients and families confronting neuropsychiatric conditions and navigating new technologies; direct the talents of Society membership and leadership to contribute to constructive and informed public policy; internationalize the Society with increased engagement in science diplomacy and deeper discourse about neuroethics among Spanish-speaking colleagues; further democratize and diversify the Society with more opportunities for early career professionals and targeted outreach to Historically Black Colleges and Universities; and develop a philanthropic strategy and stronger fiscal footing for the Society.
Dr. Fins is The E. William Davis, Jr. M.D. Professor of Medical Ethics, Chief of the Division of Medical Ethics, and Professor of Medicine in the WDOM, as well as Chair of the Ethics Committee, Attending Physician, and Director of Medical Ethics at NewYork-Presbyterian/Weill Cornell Medical College. A member of the Adjunct Faculty and Senior Attending Physician at Rockefeller University, he co-directs the Consortium for the Advanced Study of Brain Injury (CASBI) at Weill Cornell Medicine and Rockefeller. He is the Solomon Center Distinguished Scholar in Medicine, Bioethics and the Law and Visiting Professor of Law at Yale Law School where he directs CASBI@YLS.
Related Links
Press release from the International Neuroethics Society (INS)